urea has been researched along with Bullous Congenital Ichthyosiform Erythroderma in 2 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
| Excerpt | Relevance | Reference |
|---|---|---|
| " No adverse events were reported and all patients completed the 28-day treatment regimen." | 2.73 | Treatment of hyperkeratosis with Kerafoam emollient foam (30% urea) to assess effectiveness and safety within a clinical setting: a case study report. ( Goldstein, JA; Gurge, RM, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuske, M | 1 |
| Berndt, K | 1 |
| Meinel, G | 1 |
| Abraham, S | 1 |
| Oji, V | 1 |
| Reicherter, K | 1 |
| Hörtnagel, K | 1 |
| Beissert, S | 1 |
| Bauer, A | 1 |
| Goldstein, JA | 1 |
| Gurge, RM | 1 |
1 trial available for urea and Bullous Congenital Ichthyosiform Erythroderma
| Article | Year |
|---|---|
Treatment of hyperkeratosis with Kerafoam emollient foam (30% urea) to assess effectiveness and safety within a clinical setting: a case study report.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Drug Ad | 2008 |
1 other study available for urea and Bullous Congenital Ichthyosiform Erythroderma
| Article | Year |
|---|---|
Epidermolytic ichthyosis due to a de novo missense mutation c.1307T> C; p.Leu436Pro in KRT10.
Topics: Child, Preschool; Female; Heterozygote; Humans; Hyperkeratosis, Epidermolytic; Indicators and Reagen | 2019 |